Filed by Bristol-Myers Squibb Company
Pursuant to Rule 425 of the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12
of the Securities Exchange Act of 1934
Subject Company: Celgene Corporation
Commission File No.: 001-34912

Explantory Note: The following communications were made available by Bristol-Myers Squibb Company through its various social media accounts.










Celgene (NASDAQ:CELG)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Celgene Charts.
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Celgene Charts.